Cardiovascular Disease in Diabetes

Join our CE course for Physicians, Nurses, and Physician Assistants on Pharmacologic Approaches to Cardiovascular Disease in Diabetes Mellitus to gain essential insights into managing one of the most critical intersections in modern healthcare. Diabetes Mellitus remains a global epidemic and a key contributor to cardiovascular disease and heart failure. This comprehensive program delves into the complex relationship between diabetes and cardiovascular conditions, exploring the underlying pathophysiology, clinical implications of hypoglycemia, and evidence-based treatment recommendations.

Participants will examine data from recent clinical trials that have significantly impacted the understanding of antidiabetic drugs and their role in cardiovascular health. The course highlights how medications such as SGLT2 inhibitors and GLP-1 receptor agonists influence cardiovascular outcomes, extending beyond glycemic control. Updated diabetes management guidelines are covered, with a focus on improving both metabolic and cardiovascular risk factors to enhance clinical outcomes. Healthcare professionals will gain practical strategies to tailor treatment plans based on individual patient profiles, improving long-term patient outcomes.

Whether you work in primary care, endocrinology, or cardiology, this course equips you with the knowledge to apply cutting-edge pharmacotherapeutic approaches in treating patients with diabetes and cardiovascular disease.

Educational Objectives

• Explain the underlying pathophysiological relationship between diabetes mellitus and cardiovascular disease.
• Recognize how hypoglycemia can lead to cardiovascular complications and the associated risks.
• Identify cardiovascular complications commonly seen in patients with diabetes mellitus.
• Evaluate the role of antidiabetic drugs in cardiovascular health, with emphasis on recent clinical trial evidence.
• Apply current diabetes management guidelines to reduce cardiovascular disease risk in patients with diabetes.

Who Should Do This Course

This course is designed for Physicians, Nurses, and Physician Assistants working in or specializing in the following areas:

• Family Medicine
• General Practice
• Internal Medicine
• Primary Care
• Endocrinology
• Cardiology
• Family and Patient-Centered Care

It is beneficial for individuals managing chronic diseases, such as diabetes mellitus and cardiovascular disease, or for those interested in staying up-to-date on pharmacotherapy for comorbid conditions.

Did You Know?

• Over one-third of adults with diabetes also have cardiovascular disease, making CVD the leading cause of death among people with diabetes (American Heart Association, 2023).
• SGLT2 inhibitors have shown a 30-35% reduction in heart failure hospitalization among diabetic patients (NEJM, 2021).
• GLP-1 receptor agonists reduce the risk of major adverse cardiovascular events by approximately 13% (ADA, 2022).
• Intensive lifestyle interventions combined with pharmacotherapy significantly improve cardiovascular risk factors in patients with type 2 diabetes (Look AHEAD Study, 2020).
• Hypoglycemia is responsible for up to 10% of all hospital admissions for patients with diabetes over age 65 (CDC, 2022).